BAXTER 0.45% SODIUM CHLORIDE and 2.5% GLUCOSE 500mL injection AHB1023 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride and 2.5% glucose 500ml injection ahb1023

baxter healthcare pty ltd - glucose, quantity: 25 g/l; sodium chloride, quantity: 4.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.9% SODIUM CHLORIDE 450mg/50mL injection  BP bag AHB1306/1363 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.9% sodium chloride 450mg/50ml injection bp bag ahb1306/1363

baxter healthcare pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid - indications as at 9 october 2002: sodium chloride (0.9%) intravenous infusion is indicated for extracellular fluid replacement and in the management of metabolic alkalosis in the presence of fluid loss, and for restoring or maintaining the concentration of sodium and chloride ions.

BAXTER 0.45% SODIUM CHLORIDE 2.25/500mL injection AHB1313 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride 2.25/500ml injection ahb1313

baxter healthcare pty ltd - sodium chloride, quantity: 4.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - indications as at 9 october 2002: hypotonic sodium chloride (0.45%) is mainly used as a hydrating agent solution.

BAXTER POTASSIUM CHLORIDE 30 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 30 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 20 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 20 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER Chlorhexidine 0.1% Cetrimide 1% Solution AHF7978/7972/7986 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter chlorhexidine 0.1% cetrimide 1% solution ahf7978/7972/7986

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 1 mg/ml; cetrimide, quantity: 10 mg/ml - solution, irrigation - excipient ingredients: water for injections; tartrazine; glacial acetic acid - chlorhexidine acetate (0.1 %) with cetrimide (1 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

BAXTER Chlorhexidine 0.05% Cetrimide 0.5% AHF7979 solution Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter chlorhexidine 0.05% cetrimide 0.5% ahf7979 solution

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 0.5 mg/ml; cetrimide, quantity: 5 mg/ml - solution, irrigation - excipient ingredients: glacial acetic acid; water for injections; tartrazine - chlorhexidine acetate (0.05 %) with cetrimide (0.5 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

BAXTER 0.015 Chlorhexidine acetate & 0.15% cetrimide solution AHF7971/AHF7970/AHF7969 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.015 chlorhexidine acetate & 0.15% cetrimide solution ahf7971/ahf7970/ahf7969

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 0.15 mg/ml; cetrimide, quantity: 1.5 mg/ml - solution, irrigation - excipient ingredients: water for injections; glacial acetic acid; tartrazine - chlorhexidine acetate (0.015 %) with cetrimide (0.15 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

BAXTER HEPARIN SODIUM 2000IU 1000mL injection AHB0944A Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter heparin sodium 2000iu 1000ml injection ahb0944a

baxter healthcare pty ltd - heparin sodium, quantity: 2000 iu/l - injection, solution - excipient ingredients: water for injections; sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.

BAXTER Heparin Sodium 1000IU 500mL Injection AHB0953A Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter heparin sodium 1000iu 500ml injection ahb0953a

baxter healthcare pty ltd - heparin sodium, quantity: 1000 iu/l - injection, solution - excipient ingredients: sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate; water for injections - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.